Board of Directors
Meet Our Team
Mark Lievonen
Past-president of Sanofi Pasteur Limited. Co-Chair of the Government of Canada’s COVID-19 Vaccine Task Force. Director of OncoQuest Pharmaceuticals, Biome Grow, and the Gairdner Foundation. MBA, FCPA.
Walter Strapps
CEO and co-founder, Carver Biosciences Inc., a Khosla Ventures CRISPR/Cas13 antivirals development company. Previously Chief Scientific Officer of Gemini Therapeutics, head of Discovery at Intellia Therapeutics, and working with RNA therapeutics. M.A., M.Phil., Ph.D.
Neil Fraser
Past-president of Medtronic Canada. Life Sciences Strategy Council Member, Canadian Chamber of Commerce. Health Canada’s Advisory Panel on Health Innovation chaired by Dr. David Naylor. Director of CloudMD. B.A,Sc., MBA.
Michael A. Fleming
Over 35 years in the biopharma industry, spanning commercial and corporate development leadership across oncology and specialty therapeutics. Former Chief Strategy Officer and first commercial officer of Coherus BioSciences; led the company’s transformation into a commercial oncology business and architected their launch of UDENYCA®, a market-leading pegfilgrastim brand. Previously held senior commercial leadership roles at Elan, Genentech, and GlaxoSmithKline. BSc., MBA.
James Megann
25 years of experience in venture capital, capital markets and marketing. Managing Director of Numus Financial which has completed over $1.5B in transactions. He also serves on the board of Torrent Capital (TSX-V: TORR).
Wayne Myles, KC, FIIC
Lead counsel and strategic business advisor on more than 100 domestic and international acquisitions and sales, financings, government and regulatory affairs and licensing mandates. Significant and diverse experience as a director of public and private companies One of ‘Canada’s Top 25 Most Influential Lawyers’ by Canadian Lawyer Magazine.
Len Pagliaro, PhD
Prof. of Bioengineering & Laboratory Medicine at University of Washington. 24yrs exp with biotechnology products, services, & technology licensing. Developed commercialization at BioImage from concept to a $26M P&L in 4 yrs, leading to acquisition & integration by ThermoFisher Scientific. As CEO of Dynamic Light, Inc. led the spinout of an academic team from concept to first revenues in under 3 years.